retatrutide obesity clinical trial results Lilly's triple agonist delivers up to 71.2 lbs of weight loss Retatrutide Before and After: Doctor

10,11 California's spending on the three drugs approved for the weight loss indication increased fourfold from early 2024 to mid 2025, as outlined in Figure 2

Cell Physiol Biochem 51, 827841

Eligible commercially insured patients can reduce their monthly copay to $25 per prescription, with annual assistance caps typically ranging from $1,500 to $4,000 depending on individual insurance plans and program year timing

About 71% of people with prediabetes returned to normal blood sugar levels

Ozempic is a popular prescription drug right now, not just for its approved use for Type 2 diabetes, but also because of its off-label weight loss benefits

read more